Keyphrases
Neutralizing Antibodies
100%
Nanoparticles
100%
Immunogen
100%
Chikungunya Virus (CHIKV)
100%
B Domain
100%
Homotypic
100%
Mayaro Virus
66%
Immunization
22%
Neutralizing Activity
22%
Alphavirus
22%
Arthritogenic alphavirus
22%
Epitope
11%
Monoclonal Antibody
11%
Illness
11%
Virus Vaccine
11%
Clinical Manifestations
11%
Glycoprotein
11%
Broadly Neutralizing
11%
Broadly Neutralizing Antibodies
11%
Fever
11%
Rash
11%
Post-infection
11%
Arthralgia
11%
Myalgia
11%
Rheumatic Diseases
11%
Humoral Response
11%
Encephalopathy
11%
Positive-strand RNA Virus
11%
Domain-independent
11%
Immunodominant Epitopes
11%
Immunodominant
11%
Vaccine Strain
11%
Cross-neutralizing Antibody
11%
Non-neutralizing Antibodies
11%
Serum Titers
11%
Immunology and Microbiology
Neutralizing Antibody
100%
Chikungunya Virus
100%
Mayaro Virus
75%
Alphavirus
50%
Epitope
25%
Monoclonal Antibody
12%
Antibody Response
12%
Titer
12%
Glycoprotein
12%
Humoral Immunity
12%
Rheumatic Disease
12%
Positive-Strand RNA Virus
12%
Virus Vaccine
12%